Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces (Tanizawa2018)
DNA G+C(%): 34.9
|
Low T(℃): 10(+)
Mid T(℃): 40(+)
High T(℃): 45(d)
NaCl 0.5-2%: 2(+)
NaCl 3-5%: 4(neg)
pH 4.2-5.9: 4.2-5.9(+)
pH 6.0-8.0: 6.0-8.0(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
ampicillin: S(MIC50): 0.5, MIC90: 2, RNG: (0.03–8)
piper-taz: S(MIC50): 1, MIC90: 4, RNG: (0.03–16)
imipenem: S(MIC50): 0.25, MIC90: 2, RNG: (0.03–8)
|
|
|
|
linezolid: Var(MIC50): 4, MIC90: >8, RNG: (1–>8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
vancomycin: R(MIC50): >32, MIC90: >32, RNG: (0.25–>32)
|
|
metronidazole: R(MIC50): >32, MIC90: >32, RNG: (1–>32)
|
daptomycin: S(MIC50): 2, MIC90: 4, RNG: (0.25–>32)
|